"I Wanted to Broaden My Multicultural Horizons"

Natheer Masarweh's Global Executive MBA experience

27/05/2013 Barcelona

Natheer Masarweh

Natheer Masarweh earned a degree in chemistry from the University of Jordan and continued his education with a Master's degree in medical chemistry from the University of Sussex and another degree in industrial pharmaceutical science from the University of Manchester. After joining Hikma Pharmaceuticals in 1993 and assuming various roles in the company, he accepted the post of Vice President of Quality, Global Injectables in 2012.

"The decision to carry out IESE's Global Executive MBA was above all due to the fact that the program was held on different campuses and on different continents. I was looking for a program that would broaden my multicultural horizons and would expand my global knowledge of the business world," said Masarweh, citing the program's international modules.

"What I liked most was the link between theory and practice, which gave everything a greater meaning from a business perspective. I also liked the case methodology, which provided real examples that are relevant when examining different business environments. Overall, the Global Executive MBA has a 'special flavor' when comparing it to traditional programs. As an executive, it gives you the right tools for managing your company in an effective way. I experienced 18 interesting months that were full of challenges. And, indirectly, the program also teaches you how to balance professional life, family life and social activities," he said.

His work involves leading multicultural teams and working with different cultures. This was yet another reason that the Global Executive MBA experience was highly satisfying: "The program teaches you how to listen and leave aside your prejudices until you have the data on the table; and at the same time, you learn how to be more tolerant. Now I only hope to be able to use all that I have been taught during the program and fulfill my responsibilities as head of Quality, Global Injectables at Hikma Pharmaceuticals."